Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery
NCT01212562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2011-09-02
Summary
The purpose of this study is to evaluate the efficacy of cryosurgery during continuing imiquimod application in the treatment of basal cell carcinoma of the skin.
Conditions
Interventions
- PROCEDURE
-
Immunocryosurgery
Assessing the efficacy of cryosurgery during continued imiquimod application (immunocrysurgery) in the treatment of basal cell carcinoma of the skin
Sponsors & Collaborators
-
University of Ioannina
lead OTHER
Principal Investigators
-
Ioannis D Bassukas, Professor · Medical School, University of Ioannina
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-04-30
- Primary Completion
- 2010-04-30
- Completion
- 2011-08-31
Countries
- Greece
Study Locations
More Related Trials
-
Basal Cell Carcinoma Chemoprevention Trial
NCT05212246 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma
NCT00803907 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma
NCT00189241 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses
NCT00175643 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
NCT00865644 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
NCT02301494 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma
NCT01808950 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal
NCT00638651 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Vitamin C for Treatment of Basal Cell Cancer
NCT04279535 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses
NCT00774787 ·Status: COMPLETED ·Phase: PHASE4
-
Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia
NCT06840470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)
NCT01676831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparing Immune Responses to Topical Imiquimod
NCT04809662 ·Status: TERMINATED
-
Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions
NCT03233412 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Imiquimod Treatment of Oral Dysplasia
NCT07210775 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer
NCT05932511 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
NCT00668733 ·Status: COMPLETED
-
ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial
NCT00941252 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
NCT00788164 ·Status: COMPLETED ·Phase: PHASE1
-
Vismodegib for Treatment of Basal Cell Carcinoma
NCT01543581 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia
NCT01283763 ·Status: TERMINATED ·Phase: PHASE3
-
Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
NCT00504023 ·Status: COMPLETED ·Phase: NA
-
Imiquimod for Preventing Keloid Recurrence
NCT03760250 ·Status: TERMINATED ·Phase: PHASE2
-
Chemical Peels and Fractional Laser on IGF-1 Levels in Skin
NCT03775031 ·Status: UNKNOWN ·Phase: NA
-
1-Year Follow up to the 1473-IMIQ Study
NCT00114023 ·Status: COMPLETED